As of 2025-10-31, the EV/EBITDA ratio of Mersana Therapeutics Inc (MRSN) is 0.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRSN's latest enterprise value is -13.21 mil USD. MRSN's TTM EBITDA according to its financial statements is -70.56 mil USD. Dividing these 2 quantities gives us the above MRSN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 15.2x | 12.0x |
| Forward P/E multiples | 13.7x - 20.1x | 16.9x |
| Fair Price | (181.78) - (203.00) | (192.39) |
| Upside | -2054.7% - -2282.8% | -2168.7% |
| Date | EV/EBITDA |
| 2025-10-30 | 0.19 |
| 2025-10-29 | 0.17 |
| 2025-10-28 | 0.12 |
| 2025-10-27 | 0.10 |
| 2025-10-24 | 0.15 |
| 2025-10-23 | 0.15 |
| 2025-10-22 | 0.20 |
| 2025-10-21 | 0.13 |
| 2025-10-20 | 0.11 |
| 2025-10-17 | 0.15 |
| 2025-10-16 | 0.10 |
| 2025-10-15 | 0.10 |
| 2025-10-14 | 0.12 |
| 2025-10-13 | 0.14 |
| 2025-10-10 | 0.19 |
| 2025-10-09 | 0.20 |
| 2025-10-08 | 0.18 |
| 2025-10-07 | 0.28 |
| 2025-10-06 | 0.27 |
| 2025-10-03 | 0.26 |
| 2025-10-02 | 0.28 |
| 2025-10-01 | 0.28 |
| 2025-09-30 | 0.30 |
| 2025-09-29 | 0.29 |
| 2025-09-26 | 0.31 |
| 2025-09-25 | 0.34 |
| 2025-09-24 | 0.33 |
| 2025-09-23 | 0.33 |
| 2025-09-22 | 0.33 |
| 2025-09-19 | 0.33 |
| 2025-09-18 | 0.33 |
| 2025-09-17 | 0.34 |
| 2025-09-16 | 0.34 |
| 2025-09-15 | 0.34 |
| 2025-09-12 | 0.34 |
| 2025-09-11 | 0.32 |
| 2025-09-10 | 0.33 |
| 2025-09-09 | 0.30 |
| 2025-09-08 | 0.35 |
| 2025-09-05 | 0.36 |
| 2025-09-04 | 0.34 |
| 2025-09-03 | 0.35 |
| 2025-09-02 | 0.35 |
| 2025-08-29 | 0.33 |
| 2025-08-28 | 0.30 |
| 2025-08-27 | 0.31 |
| 2025-08-26 | 0.30 |
| 2025-08-25 | 0.30 |
| 2025-08-22 | 0.30 |
| 2025-08-21 | 0.27 |